| Journal Profile | |
| Journal Title | Molecular Neurodegeneration
|
| Journal Title Abbreviations | MOL NEURODEGENER |
| ISSN | 1750-1326 |
| h-index | 66 |
| CiteScore | | CiteScore | SJR | SNIP | CiteScore Rank |
|---|
| 15.00 | 4.040 | 1.671 | | Subject field | Quartiles | Rank | Percentile | Category: Neuroscience
Subcategory: Cellular and Molecular Neuroscience | Q1 | 5 / 84 |
| Category: Neuroscience
Subcategory: Molecular Biology | Q1 | 24 / 381 |
| Category: Neuroscience
Subcategory: Neurology (clinical) | Q1 | 10 / 348 |
|
|
|
| Self-Citation Ratio (2019-2020) | 1.60% |
| Official Website | https://www.springer.com/journal/13024 |
| Online Manuscript Submission | https://www.editorialmanager.com/MOND |
| Open Access | Yes |
| Publisher | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL |
| Subject Area | Medicine |
| Country/Area of Publication | ENGLAND |
| Publication Frequency | Monthly |
| Year Publication Started | 2006 |
| Annual Article Volume | 47 |
| Indexing (SCI or SCIE) | Science Citation Index Expanded
|
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1750-1326%5BISSN%5D |
| Average Duration of Peer Review * | Authorized Data from Publisher:
Data from Authors: Slow, 6-12 Week(s) |
| Competitiveness * | Data from Authors: |
| Useful Links | |
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |
